Immix BiopharmaIMMX
13F holders, Q3 2024 (September 30)25holders −6
0new positions
6sold out
1famous investor
$1.49avg. 13F price*
At the end of Q3 2024, 25 institutions reported holding Immix Biopharma Inc. (IMMX) in their 13F filings, down 6 from Q2 2024. 0 opened new positions and 6 sold out. The largest holders were AIGH Capital Management LLC ($1.7M), Bleichroeder LP ($1.3M) and Cable Car Capital, LP ($1.2M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Immix Biopharma Inc.
- CUSIP
- 45258H106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 6 | $479K |
All 13F filers, Q2 2024 → Q3 2024: 226,169 shares bought and 562,046 shares sold, net −335,877 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| AIGH Capital Management LLC | 0.78% | Reduce -20.1% | 1,123,663 | $1.7M |
| Bleichroeder LP | 0.34% | No change | 850,000 | $1.3M |
| Cable Car Capital, LP | 1.34% | No change | 796,100 | $1.2M |
| Vanguard Group Inc. | 0.00% | Add +16.7% | 698,537 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +5.6% | 150,082 | $224K |
| Morgan Stanley | 0.00% | Add +44.2% | 84,313 | $126K |
| Royal Bank of Canada | 0.00% | Add +63057.9% | 84,000 | $125K |
| Tocqueville Asset Management L.P. | 0.00% | Add +14.6% | 43,300 | $65K |
| State Street Corp. | 0.00% | No change | 42,960 | $64K |
| Northern Trust Corp. | 0.00% | No change | 38,914 | $58K |
| Private Advisor Group, LLC | 0.00% | Reduce -47.3% | 34,325 | $51K |
| Invst, LLC | 0.00% | No change | 27,000 | $40K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 26,080 | $39K |
| Tritonpoint Wealth, LLC | 0.00% | No change | 24,526 | $38K |
| Millennium Management | 0.00% | Reduce -18.2% | 21,521 | $32K |
| BlackRock, Inc. | 0.00% | — | 14,003 | $21K |
| Focus Partners Wealth | 0.00% | No change | 11,900 | $18K |
| Old National Bancorp | 0.00% | No change | 10,000 | $15K |
| UBS Group AG | 0.00% | Add +94.9% | 6,146 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -22.0% | 3,110 | $5K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,492 | $2K |
| Tortoise Investment Management, LLC | 0.00% | No change | 1,300 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 950 | $1K |
| Wells Fargo & Company | 0.00% | No change | 330 | $492 |
| Bank of America Corp. | 0.00% | No change | 115 | $171 |
"% of holder's portfolio" is IMMX's weight in each manager's 13F, not the share of Immix Biopharma Inc. the manager owns.